1. Pink Sheet
  2. >>Legal & IP

Copay Kickback Enforcement Gains Momentum: United Therapeutics Settles Charges

 
• By Cathy Kelly

Settlement is first involving a copay assistance program operated through Caring Voice Coalition since the HHS Office of Inspector General rescinded a safe harbor for the charity's activities in late November. Is it the first of a wave?

PharmacyReceipt-Dollars-PillBottles_1200x675

United Therapeutics Corp. has settled Department of Justice charges that it violated the False Claims Act and anti-kickback laws with the copay assistance it provided to Medicare beneficiaries. As part of the settlement, United Therapeutics is accepting a $210m fine and conceding to a corporate integrity agreement.

The settlement was announced Dec. 20 by the Department of Justice in conjunction with the US Attorney's Office in Massachusetts and the HHS Office of Inspector General

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Pink Sheet

Recent and Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

UK Health Data Research Service Looks ‘Encouraging’ For Industry, But Implementation Details Will Be Key

 
• By Anabel Costa-Ferreira

Marcus Vass and Vladimir Murovec of international law firm Osborne Clarke tell the Pink Sheet what the government's planned HDRS might mean for industry, and how it compares with the European Health Data Space.

EU Health Data Space May Speed Up R&D Through Access To Multi-Omics & Clinical Record Data

 
• By Eliza Slawther

The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.